Which IV drug tames severe preeclampsia better? labetalol vs hydralazine

NCT ID NCT07572656

Completed Disease control Sponsor: Muhammad Aamir Latif Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study compared two intravenous blood pressure medications, labetalol and hydralazine, in 132 pregnant women with severe preeclampsia. The goal was to see which drug more effectively lowered blood pressure to safe levels. Results could help doctors in the local setting choose the best treatment for this serious condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: labetalol and hydralazine (intravenous blood pressure medications)
What this could lead to: If one drug works better, it could help doctors choose the most effective treatment for severe preeclampsia in this population.
What could go wrong: This is a small, single-center study with no blinding, so results may not apply broadly. Both drugs are already in use, so no major breakthrough is expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

preeclampsia severe pre-eclampsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREECLAMPSIA

Contacts and locations

Show contact details

Locations

Sadiq Abbasi Hospital

Bahawalpur, Punjab Province, 63100, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.